Clinical Trial Update: Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating suvorexant for alcohol use disorder and exploring neural mechanisms; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Suvorexant (suvorexant)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Healthy Volunteers, Alcohol Use Disorder (AUD) | Phase 1, Phase 2 | Status: RECRUITING